“It is not me, it is just my brain who did it”. This could become in the future a common strategy that defendants may use in the courtrooms: admitting they committed a serious crime but arguing that, because of some...
Whether or not to provide research results or incidental findings to participants whose specimens and/or data are collected in research biobanks is a matter requiring urgent policy attention. Biobanks and research repositories are beginning to address the issue. Considerations include...
Joan Costa-Font (London School of Economics, UK) Jose Luis Fernandez (London School of Economics, UK) Katherine Swartz (Harvard University, USA)
Over the past thirty years, there has been considerable debate over the legal status of human body parts. While the body and biomaterials were traditionally considered to be outside of the realm of property in common law jurisdictions, recent legal...
The use of new biomedical technologies has led, among other factors, to an increase in demand for health care. However, for reasons that are mainly economic, legal, ethical or related to a shortage of human resources, public health services in...
Visiting researchers presentations : Jessica bell Erica Witkamp Susanne Uusitalo Yonghui Ma Jasper Littman Andrew Hoffman Yvette Van der Eijk Mark Lawrence Santiago Ivan Arroyave Zuluaga
In the field of reproductive medicine, there is a growing body of empirical data on the experience of the stakeholders (patients, professionals, and children) in gamete donation, embryo disposition decisions, genetic testing, etc. These data can influence (ethical) guidelines for...
The treatment and control of coinfections is a key object of global health. As multimorbidity becomes a growing focus in the care of chronic disease in the North and as as new treatments become available and pathogens emerge, coinfections receive...